Published in Virol J on September 29, 2006
Human cell types important for hepatitis C virus replication in vivo and in vitro: old assertions and current evidence. Virol J (2011) 0.97
Role of macrophages and monocytes in hepatitis C virus infections. World J Gastroenterol (2014) 0.88
Discovery of significant variants containing large deletions in the 5'UTR of human hepatitis C virus (HCV). Virol J (2006) 0.86
The simultaneous presence and expression of human hepatitis C virus (HCV), human herpesvirus-6 (HHV-6), and human immunodeficiency virus-1 (HIV-1) in a single human T-cell. Virol J (2007) 0.79
Analysis of the 5'UTR of HCV genotype 3 grown in vitro in human B cells, T cells, and macrophages. Virol J (2010) 0.76
Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A (1980) 30.08
Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science (1999) 24.31
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med (2005) 21.56
Complete replication of hepatitis C virus in cell culture. Science (2005) 18.59
Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science (2005) 16.84
Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A (2005) 14.78
Genetic diversity and evolution of hepatitis C virus--15 years on. J Gen Virol (2004) 6.67
Genomic diversity of human T-lymphotropic virus type III (HTLV-III). Science (1985) 5.33
Genomic analysis of the host response to hepatitis C virus infection. Proc Natl Acad Sci U S A (2002) 5.28
T cells and viral persistence: lessons from diverse infections. Nat Immunol (2005) 4.12
The Los Alamos hepatitis C sequence database. Bioinformatics (2004) 3.67
Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line. Proc Natl Acad Sci U S A (1992) 3.55
A phylogenetically conserved stem-loop structure at the 5' border of the internal ribosome entry site of hepatitis C virus is required for cap-independent viral translation. J Virol (1999) 3.13
An infectious molecular clone of a Japanese genotype 1b hepatitis C virus. Hepatology (1999) 3.00
Novel insights into hepatitis C virus replication and persistence. Adv Virus Res (2004) 2.81
Hepatitis C--global prevalence (update). Wkly Epidemiol Rec (1999) 2.75
Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection. J Virol (2003) 2.60
Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. Science (1988) 2.17
Recent advances in the molecular biology of hepatitis C virus. J Mol Biol (2001) 1.71
Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood (1996) 1.59
Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations. J Virol (1998) 1.59
Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells. J Virol (2005) 1.41
Genome of human hepatitis C virus (HCV): gene organization, sequence diversity, and variation. Microb Comp Genomics (2000) 1.40
Replication of the hepatitis C virus in cell culture. Antiviral Res (2003) 1.37
Nucleotide and amino acid complexity of hepatitis C virus quasispecies in serum and liver. J Virol (2000) 1.23
Replication of hepatitis C virus in B lymphocytes (CD19+) Blood (1999) 1.18
Wide range of quasispecies diversity during primary hepatitis C virus infection. J Virol (2005) 1.10
Hepatitis C virus internal ribosome entry site RNA contains a tertiary structural element in a functional domain of stem-loop II. Nucleic Acids Res (2001) 1.10
Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection. Eur J Immunol (2005) 1.10
Genetic variation and dynamics of hepatitis C virus replicons in long-term cell culture. J Gen Virol (2005) 0.99
Hepatitis C virus, Sjögren's syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer. Autoimmun Rev (2005) 0.97
Splenic large B-cell lymphoma in patients with hepatitis C virus infection. Hum Pathol (2005) 0.96
Replication and multiplication of hepatitis C virus genome in human foetal liver cells. Res Virol (1993) 0.95
Sampling and repeatability in the evaluation of hepatitis C virus genetic variability. J Gen Virol (2003) 0.94
Hepatitis C viral quasispecies. J Viral Hepat (1999) 0.93
Transmission of human hepatitis C virus from patients in secondary cells for long term culture. Virol J (2005) 0.92
Discovery of significant variants containing large deletions in the 5'UTR of human hepatitis C virus (HCV). Virol J (2006) 0.86
Establishment of long-term monocyte suspension cultures from normal human peripheral blood. J Exp Med (1982) 0.85
Lack of clinical significance of variability in the internal ribosome entry site of hepatitis C virus. J Med Virol (2004) 0.81
The human T-cell leukemia-lymphoma virus family. Prog Med Virol (1985) 0.78
Solution of a 20-variable 3-SAT problem on a DNA computer. Science (2002) 2.57
Serum tumor markers. Am Fam Physician (2003) 1.67
Transmission of human hepatitis C virus from patients in secondary cells for long term culture. Virol J (2005) 0.92
Discovery of significant variants containing large deletions in the 5'UTR of human hepatitis C virus (HCV). Virol J (2006) 0.86
The simultaneous presence and expression of human hepatitis C virus (HCV), human herpesvirus-6 (HHV-6), and human immunodeficiency virus-1 (HIV-1) in a single human T-cell. Virol J (2007) 0.79
Self-assembly of DNA double-double crossover complexes into high-density, doubly connected, planar structures. J Am Chem Soc (2005) 0.78
Oral doxycycline for treatment of neurosyphilis in two patients infected with human immunodeficiency virus. Pharmacotherapy (2010) 0.77
Analysis of the 5'UTR of HCV genotype 3 grown in vitro in human B cells, T cells, and macrophages. Virol J (2010) 0.76
Mycobacterium szulgai in a patient with advanced acquired immunodeficiency syndrome: an unusual pathogen with unusual multidrug resistance. Pharmacotherapy (2006) 0.75